Cardinal Health (CAH) Beats on Q4 Earnings, Ups '24 EPS View
Cardinal Health's (CAH) fourth-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
Cardinal Health Stock Pops on Beat-and-Raise
Cardinal Health Inc (NYSE:CAH) stock is gapping higher on the charts today, after the company announced strong fiscal fourth-quarter results and raised its full-year guidance.
Here's What Key Metrics Tell Us About Cardinal (CAH) Q4 Earnings
Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Cardinal Health (CAH) Q4 Earnings and Revenues Top Estimates
Cardinal Health (CAH) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.72 per share. This compares to earnings of $1.55 per share a year ago.
Top 3 Health Care Stocks That May Crash In August
As of Aug 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Cardinal Health lifts 2025 profit outlook on strong demand for costly specialty drugs
Cardinal Health raised its 2025 profit forecast on Wednesday betting on strong demand for branded and specialty medicines at its pharmaceuticals unit.
Cardinal Health's stock up 5% after earnings beat and raised guidance
Cardinal Health Inc.'s stock CAH, +1.91% rose 5% early Wednesday, after the drug distributor and medical products maker beat estimates for the second quarter and raised its guidance. Dublin, Ohio-based Cardinal Health had net income of $235 million, or 96 cents a share, for the quarter, after a loss of $56 million, or 22 cents a share, in the year-earlier period.
Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Cardinal Health, Inc. CAH is set to release earnings results for its fourth quarter, before the opening bell on Aug. 14, 2024.
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
What's in Store for Cardinal Health (CAH) in Q4 Earnings?
Cardinal Health's (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
How To Earn $500 A Month From Cardinal Health Stock Ahead Of Q4 Earnings
Cardinal Health, Inc. CAH expects to release earnings results for its fourth quarter, before the opening bell on Wednesday, Aug. 14.
